BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced that it has entered into a Memorandum of Understanding (MOU) ...

ALS is a progressive neurodegenerative disease that gradually impairs muscle ... The most commonly reported side effect was pain, redness and swelling where the drug was infused, which were ...

Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. Medicare covers one kit per year under Original Medicare (Parts A and ...

Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's ...

STOCKHOLM, SE / ACCESSWIRE / November 11, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - Septem ...

Reg Wydeven is a partner with the Appleton-based law firm of McCarty Law LLP. He writes a weekly column for The Post-Crescent ...

Our technology constitutes a platform to address dozens of indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum ... auch der Bedarf an Energie.

Kelly, a 77-year-old Oak Park retiree, is now dealing with the same disease himself. While his cancer is under control at the moment, if it worsens, if he’s given a terminal diagnosis and his pain can ...

A few therapies are approved to treat ALS, but their ability to slow disease progression and extend survival is ... The most common adverse reactions included constipation, pain at the injection site, ...

In addition to trauma and opioid use disorders, cannabis has already been approved for medical use for conditions ranging ...

Biogen's Q3 earnings report shows flat growth but highlights its value for risk-tolerant investors in CNS disease treatment.